Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.

Domenico Marco Romeo, Eugenio Maria Mercuri, Marika Pane, Claudia Brogna, Marco Luigetti, Sara Scalise, Gloria Ferrantini, Raffaele Manna, G Norcia, B Berti

Research output: Contribution to journalMeeting Abstract


We report the clinical case of a nine-year-old girl who presented with progressive motor neuropathy, revealed via the detection of a higher delay in F-wave recording using digitalized nerve conduction/electromyography. Since the lupus anticoagulant (LAC) positivity, detected using diluted Russell viper venom time (dRVVT), switched to persistent serological anticardiolipin immunoglobulin G (IgG) positivity, a possible non-thrombotic antiphospholipid antibody (aPL)-related clinical manifestation was suspected, and intravenous immunoglobulin treatment (IVIG) was started. The IVIG treatment was well tolerated and the complete resolution of motor impairment was obtained after the third IVIG infusion. Our findings suggest that it could be useful to check for antiphospholipid antibodies in children with a rapid onset of progressive neurological signs in order to provide the beneficial use of IVIG in the treatment of pediatric aPL neurological conditions.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalBrain Sciences
Publication statusPublished - 2020


  • neuropathy


Dive into the research topics of 'Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies.'. Together they form a unique fingerprint.

Cite this